Daniella Motta da Costa Dan

ORCID: 0009-0003-5239-8508
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiovascular Function and Risk Factors
  • Eosinophilic Disorders and Syndromes
  • Advanced Chemical Sensor Technologies
  • Whipple's Disease and Interleukins
  • Heart Failure Treatment and Management
  • Cardiovascular Issues in Pregnancy
  • Viral Infections and Immunology Research
  • GDF15 and Related Biomarkers
  • Pulmonary Hypertension Research and Treatments

Introduction Heart failure (HF) can be a serious disease if not treated properly. One of the markers severity is precisely hospitalization due to HF, often called acute HF or acutely decompensated (ADHF). ADHF involves patients with new an exacerbation chronic HF. The most common symptoms and signs in are dyspnea edema lower limbs. Dyspnea, when it occurs isolation, no specific hinder diagnosis. In this context, [...]

10.36660/abchf.20230072 article EN ABC Heart Failure & Cardiomyopathy 2023-01-01

Diagnosis The criterion for the diagnostic confirmation of myocarditis defined by 2013 European and Brazilian Myocarditis Guidelines is identification myocardial inflammation endomyocardial biopsy (EMB)., This criterion, used solely without option classifying clinical suspicion, does not mirror practice in real world, where only a minority patients specialized centers are referred investigation through EMB with or exclusion, most have diagnosis suspicion myocarditis. [...]

10.36660/abchf.20230037 article EN ABC Heart Failure & Cardiomyopathy 2023-09-01

Introduction Heart failure (HF) is characterized by progressive functional or structural worsening of the myocardium. Despite significant therapeutic advances that have improved survival and quality life, HF still has high morbidity mortality rates. Patients with may progress refractory disease, whose gold standard treatment heart transplantation (HT)., The assessment pulmonary hemodynamics indicated for HT candidates. presence fixed hypertension (PH) a contraindication because it promotes...

10.36660/abchf.20220048 article EN ABC Heart Failure & Cardiomyopathy 2022-01-01
Coming Soon ...